인쇄하기
취소

Dong-A and Shanghai Zhongxi Sunve sign license agreement for Zydena

Published: 2011-08-12 06:56:00
Updated: 2011-08-12 06:56:00
Dong-A Pharmaceutical Co. said Tuesday that it has signed an agreement with Shanghai Zhongxi Sunve Pharmaceutical Co. based in China to market Dong-A’s orally-administered udenafil product, a phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction (ED) in China.

“We are extremely pleased to see the marketing of Zydena in China. This is an important milestone in ou...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.